240 related articles for article (PubMed ID: 29463776)
1. Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.
Tripathi R; Fiore LS; Richards DL; Yang Y; Liu J; Wang C; Plattner R
Sci Signal; 2018 Feb; 11(518):. PubMed ID: 29463776
[TBL] [Abstract][Full Text] [Related]
2. c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer.
Fiore LS; Ganguly SS; Sledziona J; Cibull ML; Wang C; Richards DL; Neltner JM; Beach C; McCorkle JR; Kaetzel DM; Plattner R
Oncogene; 2014 Sep; 33(36):4508-4520. PubMed ID: 24096484
[TBL] [Abstract][Full Text] [Related]
3. EnABLing Cathepsin-Driven Melanoma Metastasis.
Tripathi R; Plattner R
Mol Cell Oncol; 2018; 5(4):e1458016. PubMed ID: 30250913
[TBL] [Abstract][Full Text] [Related]
4. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.
Ganguly SS; Fiore LS; Sims JT; Friend JW; Srinivasan D; Thacker MA; Cibull ML; Wang C; Novak M; Kaetzel DM; Plattner R
Oncogene; 2012 Apr; 31(14):1804-16. PubMed ID: 21892207
[TBL] [Abstract][Full Text] [Related]
5. TGF-β signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells.
Yin M; Soikkeli J; Jahkola T; Virolainen S; Saksela O; Hölttä E
Am J Pathol; 2012 Dec; 181(6):2202-16. PubMed ID: 23063511
[TBL] [Abstract][Full Text] [Related]
6. Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.
Jain A; Tripathi R; Turpin CP; Wang C; Plattner R
Oncogene; 2017 Aug; 36(32):4585-4596. PubMed ID: 28368422
[TBL] [Abstract][Full Text] [Related]
7. Imatinib reverses doxorubicin resistance by affecting activation of STAT3-dependent NF-κB and HSP27/p38/AKT pathways and by inhibiting ABCB1.
Sims JT; Ganguly SS; Bennett H; Friend JW; Tepe J; Plattner R
PLoS One; 2013; 8(1):e55509. PubMed ID: 23383209
[TBL] [Abstract][Full Text] [Related]
8. Cystatin E/M suppresses legumain activity and invasion of human melanoma.
Briggs JJ; Haugen MH; Johansen HT; Riker AI; Abrahamson M; Fodstad Ø; Maelandsmo GM; Solberg R
BMC Cancer; 2010 Jan; 10():17. PubMed ID: 20074384
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B inhibition interferes with metastatic potential of human melanoma: an in vitro and in vivo study.
Matarrese P; Ascione B; Ciarlo L; Vona R; Leonetti C; Scarsella M; Mileo AM; Catricalà C; Paggi MG; Malorni W
Mol Cancer; 2010 Aug; 9():207. PubMed ID: 20684763
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral gene delivery of anti-cathepsin L single-chain variable fragment by lentiviral vector inhibits tumor progression induced by human melanoma cells.
Frade R; Rousselet N; Jean D
Cancer Gene Ther; 2008 Sep; 15(9):591-604. PubMed ID: 18617916
[TBL] [Abstract][Full Text] [Related]
11. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
[TBL] [Abstract][Full Text] [Related]
12. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin K in melanoma invasion.
Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
J Invest Dermatol; 2008 Sep; 128(9):2281-8. PubMed ID: 18368130
[TBL] [Abstract][Full Text] [Related]
14. Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl.
Lu Z; Jin Y; Chen C; Li J; Cao Q; Pan J
Mol Cancer; 2010 May; 9():112. PubMed ID: 20482842
[TBL] [Abstract][Full Text] [Related]
15. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
16. ABL allosteric inhibitors synergize with statins to enhance apoptosis of metastatic lung cancer cells.
Luttman JH; Hoj JP; Lin KH; Lin J; Gu JJ; Rouse C; Nichols AG; MacIver NJ; Wood KC; Pendergast AM
Cell Rep; 2021 Oct; 37(4):109880. PubMed ID: 34706244
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumorigenicity and metastasis of human melanoma cells by anti-cathepsin L single chain variable fragment.
Rousselet N; Mills L; Jean D; Tellez C; Bar-Eli M; Frade R
Cancer Res; 2004 Jan; 64(1):146-51. PubMed ID: 14729618
[TBL] [Abstract][Full Text] [Related]
18. Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma.
Fröhlich E; Schlagenhauff B; Möhrle M; Weber E; Klessen C; Rassner G
Cancer; 2001 Mar; 91(5):972-82. PubMed ID: 11251949
[TBL] [Abstract][Full Text] [Related]
19. c-Abl and Arg tyrosine kinases regulate lysosomal degradation of the oncoprotein Galectin-3.
Li X; Ma Q; Wang J; Liu X; Yang Y; Zhao H; Wang Y; Jin Y; Zeng J; Li J; Song L; Li X; Li P; Qian X; Cao C
Cell Death Differ; 2010 Aug; 17(8):1277-87. PubMed ID: 20150913
[TBL] [Abstract][Full Text] [Related]
20. Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.
Fröhlich E; Möhrle M; Klessen C
Arch Dermatol Res; 2004 Mar; 295(10):411-21. PubMed ID: 14767779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
